About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials | 3,720 Studies Recruiting

Clinical TrialsMultiple Sclerosis

Multiple Sclerosis Clinical Trials

Browse 3,720 clinical trials for multiple sclerosis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 261-280 of 3,720 trials

UnknownMultimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum DisordersTo investigate multimodel MRI exploring the pathophysiology of multiple sclerosis and neuromyelitis optica spectrum disorders.NCT02836327·Beijing, Beijing Municipality UnknownInvestigation of Factors Affecting Functional Capasity in Multiple SclerosisFunctional exercise capacities of Multiple Sclerosis (MS) patients decrease with the effect of symptoms and sedentary lifestyle.NCT06090084

Related Searches

Data from ClinicalTrials.govTerms

CompletedLong-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple SclerosisThis study consisted of a two year dose blinded phase during which patients received one of five doses of siponimod (10, 2, 1.25, 0.5 or 0.25mg) following which patients were…NCT01185821·Miami, Florida and 45 others

TerminatedImpact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) ParticipantsThe primary objective of this study is to assess the effect of natalizumab compared to fingolimod on the evolution of new on-treatment T1-gadolinium-enhancing (Gd+) lesions to…NCT02342704·Aurora, Colorado and 41 others

WithdrawnEffect of Alemtuzumab on Microglial Activation Positron Emission Tomography (PET) in Multiple SclerosisSpecific Aims The specific aims of the study are: * Primary Objective: To assess the effect of alemtuzumab on microglial activation in MS patients.NCT03983252·Boston, Massachusetts

RecruitingMRI-Based Lesion Differentiation in Older Patients With Multiple SclerosisThis study investigates whether an advanced MRI technique called Quantitative Susceptibility Mapping (QSM) can improve the differentiation of white matter lesions in people aged…NCT07444047·Oslo, Oslo

CompletedMeasuring Signatures in the Fluid Surrounding the Spinal Cord in Patients Who Have Problems With Intrathecal Drug DeliveryThe purpose of this study is to record signatures from the fluid surrounding the spinal cord from people who have an implanted drug infusion system.NCT01117090·Indianapolis, Indiana and 1 other

UnknownImpact of Tecfidera on Gut MicrobiotaObjectives: Dimethyl fumarate (DMF) therapy may cause a measureable change in bacterial species of the gut. The primary objectives of this study are: 1.NCT02736279·Kirkland, Washington

CompletedSafety Study of GNbAC1 Monoclonal Antibody in Healthy Male VolunteersIn this clinical study, the safety and tolerability of GNbAC1 as a treatment for MS patients will be evaluated in healthy male volunteers.NCT02452996·Berlin

RecruitingEscalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50The objective of this study is to evaluate the risk of inflammatory disease activity by retrospectively comparing two therapeutic strategies (escalation group and induction group).NCT07313462·Strasbourg

Active not recruitingEffects of Ocrevus in Relapsing Multiple SclerosisThe purpose of this study is to test if people with relapsing multiple sclerosis (RMS) can improve ambulatory functions after one-year treatment with Ocrevus in comparison with…NCT04387734·Atlanta, Georgia and 1 other

UnknownEffects of Spinal Cord Injury on Female Sexual ResponseThe long term aims of this project are to 1) Understand the effect of varying degrees and levels of SCI and dysfunction(SCI/D)on females sexual response: 2) Identify the specific…NCT00142714·Birmingham, Alabama

CompletedBiomarkers and Response to Natalizumab for Multiple Sclerosis TreatmentInformation from blood samples may help us for choosing the best treatment in future personalized medicine.NCT00942214·Toulouse

RecruitingThe Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.Migraine is a frequent and debilitating neurologic disorder.NCT06426316·Clermont-Ferrand, AURA

CompletedOpen-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 TrialThe purpose of this study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months, or until it becomes commercially…NCT00648908·Phoenix, Arizona and 31 others

UnknownThe SEMS Project: Staying Employed With MSDescription of Project: Multiple sclerosis (MS), a disorder of young and middle aged adults, is known to have a grave impact on one's well-being and incurs a significant cost to…NCT03647904·East Hanover, New Jersey

CompletedWii FIT Balance Board to Recording Balance Parameters in Multiple Sclerosis SubjectsBalance disorders are frequently observed in patients with Multiple Sclerosis (MS) and the deterioration of the static and dynamic control of balance is an important and basic…NCT02287948·Ferrara, Ferrara

CompletedAerobic Exercise for Urinary Incontinence in Multiple SclerosisLimited studies has investigated the effect of aerobic exercise program on urinary inconitenance in people with multiple sclerosis.NCT06843915·Irbid

CompletedMotivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCIThis study compares two approaches to helping people who are aging with MS or SCI and are experiencing depressed mood to become more physically active.NCT00947232·Seattle, Washington

UnknownStudy of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced SubjectsThe purpose of this study is to treat prospectively documented clinic patients with treatment-refractory multiple sclerosis that are naïve to alemtuzumab.NCT01624714·Franklin, Tennessee

PreviousPage 14 of 186Next